dr. mesa on the utility of fedratinib for patients with myelofibrosis who progress on ruxolitinib
Published 4 years ago • 92 plays • Length 1:11Download video MP4
Download video MP3
Similar videos
-
1:00
dr. mesa on the utility of ruxolitinib versus fedratinib in myelofibrosis
-
2:13
dr. mesa on the efficacy of fedratinib in patients with myelofibrosis and low platelet counts
-
1:29
dr. mesa on the fda approval of fedratinib in myelofibrosis
-
1:24
dr. mesa on current data with ruxolitinib and fedratinib in myelofibrosis
-
1:42
dr. mesa on ruxolitinib vs fedratinib in myelofibrosis treatment
-
1:12
dr. mesa on the differences between fedratinib and ruxolitinib in myelofibrosis
-
1:16
dr. mesa on the fda approval of fedratinib in myelofibrosis
-
22:26
what's your approach? treating myelofibrosis
-
1:25
dr. bose on the utility of ruxolitinib in myelofibrosis
-
2:03
dr. mesa on jakarta-2 reanalysis for myelofibrosis
-
0:57
dr. mesa on challenges in myelofibrosis treatment
-
7:43
the role of fedratinib in myelofibrosis
-
0:50
dr. snyder on how ruxolitinib and fedratinib may pave the way to transplant in myelofibrosis
-
1:40
considering fedratinib or ruxolitinib in the frontline setting for treatment of myelofibrosis
-
0:56
dr. saint fleur-lominy on the use of ruxolitinib versus fedratinib in mpns
-
0:59
dr. michaelis on fedratinib in myelofibrosis treatment
-
1:13
dr. mesa on new trials and agents in the pipeline in myelofibrosis
-
1:10
dr. ruben mesa on comfort-1 for myelofibrosis
-
2:34
dr. mesa on ruxolitinib in myelofibrosis